Sulakhe P V, Vo X T
Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Mol Cell Biochem. 1995 Aug-Sep;149-150:103-26. doi: 10.1007/BF01076569.
Protein phosphorylation was investigated in [32P]-labeled cardiomyocytes isolated from adult rat heart ventricles. The beta-adrenergic stimulation (by isoproterenol, ISO) increased the phosphorylation of inhibitory subunit of troponin (TN-I), C-protein and phospholamban (PLN). Such stimulation was largely mediated by increased adenylyl cyclase (AC) activity, increased myoplasmic cyclic AMP and increased cyclic AMP dependent protein kinase (A-kinase)-catalyzed phosphorylation of these proteins in view of the following observations: (a) dibutyryl-and bromo-derivatives of cyclic AMP mimicked the stimulatory effect of ISO on protein phosphorylation while (b) Rp-cyclic AMP was found to attenuate ISO-dependent stimulation. Unexpectedly, 8-bromo cyclic GMP was found to markedly increase TN-I and PLN phosphorylation. Both beta 1- and beta 2-adrenoceptors were present and ISO binding to either receptor was found to stimulate myocyte AC. However, the stimulation of the beta 2-AR only marginally increased while the stimulation of beta 1-AR markedly increased PLN phosphorylation. Other stimuli that increase tissue cyclic AMP levels also increased PLN and TN-I phosphorylation and these included isobutylmethylxanthine (non-specific phosphodiesterase inhibitor), milrinone (inhibits cardiotonic inhibitable phosphodiesterase, sometimes called type III or IV) and forskolin (which directly stimulates adenylyl cyclase). Cholinergic agonists acting on cardiomyocyte M2-muscarinic receptors that are coupled to AC via pertussis toxin(PT)-sensitive G proteins inhibited AC and attenuated ISO-dependent increases in PLN and TN-I phosphorylation. The in vivo PT treatment, which ADP-ribosylated Gi-like protein(s) in the myocytes, markedly attenuated muscarinic inhibitory effect on PLN and TN-I phosphorylation on one hand and, increased the beta-adrenergic stimulation, on the other. Controlled exposure of isolated myocytes to N-ethyl maleimide, also led to the findings similar to those seen following the PT treatment. Exposure of myocytes to phorbol, 12-myristate, 13-acetate (PMA) increased the protein phosphorylation, augmenting the stimulation by ISO, and such augmentation was antagonized by propranolol suggesting modulation of the beta-adrenoceptor coupled AC pathway by PMA. Okadaic acid (OA) exposure of myocytes also increased protein phosphorylation with the results supporting the roles for type 1 and 2A protein phosphatases in the dephosphorylation of PLN and TN-I. Interestingly OA treatment attenuated the muscarinic inhibitory effect which was restored by subsequent brief exposure of myocytes to PMA. While the stimulation of alpha adrenoceptors exerted little effect on the phosphorylation of PLN and TN-I, inactivation of alpha adrenoceptors by chloroethylclonidine (CEC), augmented beta-adrenergically stimulated phosphorylation. KCl-dependent depolarization of myocytes was observed to potentiate ISO-dependent increase in phosphorylation (incubation period 15 sec to 1 min) as well as to accelerate the time-dependent decline in this phosphorylation seen upon longer incubation. Verapamil decreased ISO-stimulated protein phosphorylation in the depolarized myocytes. Depolarization was found to have little effect on the muscarinic inhibitory action on phosphorylation. Prior treatment of myocytes with PMA, was found to augment ISO-stimulated protein phosphorylation in the depolarized myocytes. Such augmented increases were completely blocked by propranolol. Forskolin also stimulated PLN and TN-I phosphorylation. Prior exposure of myocytes to forskolin followed by incubation in the depolarized and polarized media showed that PLN was dephosphorylated more rapidly in the depolarized myocytes. The results support the view that both cyclic AMP and calcium signals cooperatively increase the rates of phosphorylation of TN-I and PLN in the depolarized cardiomyocytes during beta-adrenergic stimulation. (ABSTRACT TRUNCATED)
在从成年大鼠心室分离的[32P]标记心肌细胞中研究了蛋白质磷酸化。β-肾上腺素能刺激(通过异丙肾上腺素,ISO)增加了肌钙蛋白抑制亚基(TN-I)、C蛋白和受磷蛋白(PLN)的磷酸化。鉴于以下观察结果,这种刺激很大程度上是由腺苷酸环化酶(AC)活性增加、肌浆环磷酸腺苷(cAMP)增加以及环磷酸腺苷依赖性蛋白激酶(A激酶)催化的这些蛋白质磷酸化增加介导的:(a)环磷酸腺苷的二丁酰基和溴衍生物模拟了ISO对蛋白质磷酸化的刺激作用,而(b)Rp-环磷酸腺苷被发现可减弱ISO依赖性刺激。出乎意料的是,发现8-溴环磷酸鸟苷(cGMP)可显著增加TN-I和PLN的磷酸化。β1和β2肾上腺素能受体均存在,并且发现ISO与任一受体结合均可刺激心肌细胞AC。然而,β2-肾上腺素能受体(β2-AR)的刺激仅略微增加,而β1-肾上腺素能受体(β1-AR)的刺激则显著增加PLN磷酸化。其他增加组织环磷酸腺苷水平的刺激也增加了PLN和TN-I的磷酸化,这些刺激包括异丁基甲基黄嘌呤(非特异性磷酸二酯酶抑制剂)、米力农(抑制强心可抑制磷酸二酯酶,有时称为III型或IV型)和福斯高林(直接刺激腺苷酸环化酶)。作用于心肌细胞M2-毒蕈碱受体的胆碱能激动剂通过百日咳毒素(PT)敏感的G蛋白与AC偶联,抑制AC并减弱ISO依赖性的PLN和TN-I磷酸化增加。体内PT处理使心肌细胞中的Gi样蛋白进行ADP核糖基化,一方面显著减弱了毒蕈碱对PLN和TN-I磷酸化的抑制作用,另一方面增加了β-肾上腺素能刺激。将分离的心肌细胞控制性暴露于N-乙基马来酰亚胺,也得到了与PT处理后相似的结果。将心肌细胞暴露于佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)可增加蛋白质磷酸化,增强ISO的刺激作用,并且这种增强作用被普萘洛尔拮抗,提示PMA对β-肾上腺素能受体偶联的AC途径有调节作用。心肌细胞暴露于冈田酸(OA)也增加了蛋白质磷酸化,结果支持1型和2A蛋白磷酸酶在PLN和TN-I去磷酸化中的作用。有趣的是,OA处理减弱了毒蕈碱的抑制作用,随后将心肌细胞短暂暴露于PMA可恢复该作用。虽然α肾上腺素能受体的刺激对PLN和TN-I的磷酸化影响很小,但氯乙可乐定(CEC)使α肾上腺素能受体失活,增强了β-肾上腺素能刺激的磷酸化。观察到KCl依赖性的心肌细胞去极化增强了ISO依赖性的磷酸化增加(孵育期15秒至1分钟),并加速了长时间孵育后这种磷酸化的时间依赖性下降。维拉帕米降低了去极化心肌细胞中ISO刺激的蛋白质磷酸化。发现去极化对毒蕈碱对磷酸化的抑制作用影响很小。预先用PMA处理心肌细胞,发现在去极化心肌细胞中增强了ISO刺激的蛋白质磷酸化。这种增强的增加被普萘洛尔完全阻断。福斯高林也刺激PLN和TN-I磷酸化。预先将心肌细胞暴露于福斯高林,然后在去极化和极化培养基中孵育,结果显示PLN在去极化心肌细胞中去磷酸化更快。结果支持这样的观点,即在β-肾上腺素能刺激期间,环磷酸腺苷和钙信号协同增加去极化心肌细胞中TN-I和PLN的磷酸化速率。(摘要截断)